Acquired Hemophilia Treatment Market


Posted August 9, 2022 by Drachana

The continuous hike in the cases of acquired hemophilia in the global population and a rising awareness in diagnosis and treatment of rare diseases have helped in the significant growth of the market globally.

 
Demand Analysis of Acquired Hemophilia Treatment Market Overview:
Governments, and private organizations have also been extending tremendous support in form of funds and investment to develop & provide better and more efficient acquired hemophilia treatments. Takeda Pharmaceutical Company Limited announced the U.S. Foods and Drugs Administration (FDA) approval to myPKFiT for ADYNOVATE, a web-based software and mobile application i.e., pharmacokinetic (PK)-dosing software for hemophilia A patients. This software helps healthcare professionals to estimate the full PK curve (Pharmacokinetic Curve).
The global acquired hemophilia treatment market was pegged at ~US$ 11 billion in 2021. The market is expected to witness a CAGR of ~5.06% from 2022 to 2030
The incidence of acquired hemophilia is expected to grow during the forecast period. Acquired hemophilia more commonly occurs in males, as females commonly are the carriers of this malfunctioning gene. The growth in the number of patients has a great impact on the market and can be considered as a leading factor in propelling the market growth globally. For instance, according to the 2020 report of the U.S. National Library of Medicine, the incidence of acquired hemophilia in children (age group from 1-16 years) is 0.045 per million per year and 14.7 per million per year (age group from 17-85 years old).
To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/acquired-hemophilia-treatment-market/7748
Key players:
Pfizer, Inc., Genentech Inc., CSL Behring, Biogen Idec, Inc., Baxter International, Inc., Hospira, Inc., Novo Nordisk AS, Biotest AG., Octapharma AG and Spark Therapeutics Inc
Segmentation By Type:
• Hemophilia A
• Hemophilia B
• Hemophilia C
By Therapy
• Gene Therapy
• Immune Tolerance Induction Therapy
• Replacement Therapy
Regional Analysis-
• The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.
• Major factors contributing to the growth of Acquired Hemophilia Treatment market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Acquired Hemophilia Treatment, and increasing research activities in the field of Acquired Hemophilia Treatment.
• The emergence of local players and new product launches has also played a critical role in boosting the Acquired Hemophilia Treatment market in this region.
Browse the full report now: https://growthplusreports.com/report/acquired-hemophilia-treatment-market/7748
Key Questions Answered in the Report Include:
(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.
(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?
(3) What are the major global Acquired Hemophilia Treatment Market trends influencing the development of the market?
(4) What are the vital results of SWOT analysis of the major players operating in the Acquired Hemophilia Treatment Market?
(5) What are the potential growth opportunities and threats faced by Major competitors in the market?
About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By growthplusreports
Country India
Categories Biotech , Health , Lifestyle
Tags acquired , hemophilia , market , treatment
Last Updated August 9, 2022